Tolerability and feasibility of a prebiotic intervention in PD patients
gastrointestinal symptoms
Participants were moderately accordant to a Mediterranean diet at baseline (median 8.5, IQR 4.3). No differences in accordance existed between newly diagnosed, non-medicated, and treated participants (Mann–Whitney Tolerability and gastrointestinal symptoms before and after the prebiotic interventionTolerability was assessed using a post bar survey and gastrointestinal symptoms were assessed via the PROMIS gastrointestinal symptom scale. The tolerability questionnaire was a Likert scale 1–10. Data are shown as *Significance: Consumption of prebiotics can influence gastrointestinal symptomsAs an exploratory analysis, an assessment of UPDRS score was conducted. The 10-day prebiotic intervention was associated with a decrease (Wilcoxon signed-rank test: 